Author:
Laohavinij Sudsawat,Wedge Stephen R.,Lind Micheal J.,Bailey Nigel,Humphreys Alison,Proctor Madeleine,Chapman Fiona,Simmons Dorothy,Oakley Avril,Robson Lesley,Gumbrell Lyndsey,Taylor Gordon A.,Thomas Huw D.,Boddy Alan V.,Newell David R.,Calvert A. Hilary
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference35 articles.
1. Taylor EC, Harrington PJ, Fletcher SR, Beardley GP, Moran RG: Synthesis of the antileukemic agents 5,10-dideazaaminop-terin and 5,10-dideaza-5,6,7,8-tetra-hydroaminopterin. J Med Chem 28:914–921, 1985
2. Beardsley GP, Moroson BA, Taylor EC, Moran RG: A new folate antimetabolite, 5,10-Dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis. J Biol Chem 264:328–333, 1989
3. Jansen G, Westerhof GR, Kathmann I, Rijksen G, Schornagel JH: Growth-inhibitory effects of 5,10-dideazatetrahydrofolic acid on variant murine L1210 and human CCRF-CEM leukemia cells with different membrane transport characteristics for (anti)folate compounds. Cancer Chemother Pharmacol 28:115–117, 1991
4. Shih C, Grindey GB, Houghton PJ, Houghton JA: In vivo antitumour activity of 5,10-Dideazatetrahydrofolic acid (DDATHF) and its diastereomeric isomers. Proc Amer Assoc Cancer Res 29:283, 1988
5. Nelson R, Butler F, Dugan W Jr, Davisland C, Stone M, Dyke R: Phase I clinical trial of LY264618 (dideazatetrahydrofolic acid; DDATHF). Proc Amer Soc Clin Oncol 9:76, 1990
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献